Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Belinda Mak"'
Autor:
Valentina Grossi, Oliver Cumming, James Benjamin Tidwell, Ann Thomas, Mary Eyram Ashinyo, Joanna Esteves Mills, Kahtan Al-Shabi, Jenala Chipungu, Bruce Gordon, Nadia Abdalla, Fodé Ousmane Bangoura, Katrina Charles, Arnold Oredola Cole, Betsy Engebretson, Kitka Goyol, Catherine Fallon Grasham, Sophie Hickling, Safo Kalandarov, Alemu Kejela Ababu, Karimzoda Kholmuhammad, Nicole Klaesener-Metzner, Ziggy Kugedera, Akosua Kwakye, Andrea Lee-Llacer, Pauke P Maani, Belinda Makhafola, Alyaa Mohamed, Md Monirul Alam, Bella Monse, Henry Northover, Aarin Palomares, Nilusha Patabendi, Nathaniel Paynter, Om Prasad-Gautam, Sudan Raj Panthi, Lisa Rudge, Shiny Saha, Ion Salaru, Gustavo Saltiel, Laurent Sax, Mir Abdus Shahid, Mahmud Shamsul Gafur, Siddhi Shrestha, Katalin Szeberényi, Victoria Trinies, Osman Yiha, Ruslan Ziganshin, Rola Al-Emam
Publikováno v:
BMJ Global Health, Vol 8, Iss 10 (2023)
Externí odkaz:
https://doaj.org/article/0d92b131f1d649b095e158f789eda5ef
Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?
Autor:
Yock Young Dan, Seng Gee Lim, How Cheng Low, Kieron Lim, Belinda Mak, Myat Oo Aung, Poh Seng Tan, Guan Huei Lee, Yin Mei Lee, Maung Aye Thwin
Publikováno v:
Journal of Medical Virology. 85:26-33
Entecavir switch is one of the treatment options for lamivudine-resistant hepatitis B (HBV) patients in Asia. This study examined the outcome of patients with different baseline resistance genotypes in a cohort study. In this study, 14 patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::224dc185e91b168ea8279c36f9eb4fd3
https://doi.org/10.1002/jmv.23392
https://doi.org/10.1002/jmv.23392
Autor:
Dede Selamat Sutedja, Yock Young Dan, Myat Oo Aung, Belinda Mak, Seng Gee Lim, Mark L. Fernandes, How Cheng Low, Vincent Lai, Guan Huei Lee, Yin Mei Lee
Publikováno v:
Journal of Clinical Gastroenterology. 45:818-823
GOALS To determine the clinical outcome of chronic hepatitis B cirrhotics on antiviral therapy. BACKGROUND The long-term outcome of hepatitis B cirrhotics on therapy remains to be characterized. METHODS A large clinic cohort of chronic hepatitis B ci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eaba4273257f17369548eb50a23bfad
https://doi.org/10.1097/mcg.0b013e318214ab5d
https://doi.org/10.1097/mcg.0b013e318214ab5d
Autor:
Seng Gee Lim, Keat Hong Lee, Myat Oo Aung, Belinda Mak, Charlene S L Soon, Stephanie W M Chung
Publikováno v:
Antiviral therapy. 18(5)
Background Little is known about patient preferences for selection of chronic hepatitis B (CHB) treatment. This issue is important as it affects the therapeutic choices available for patients and, in the long term, the health of CHB patients. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b74532f4cee25a4c90888a1c0779d015
https://pubmed.ncbi.nlm.nih.gov/23232291
https://pubmed.ncbi.nlm.nih.gov/23232291
Publikováno v:
Hepatology (Baltimore, Md.). 47(4)
The relationship between stages of chronic hepatitis B liver disease and health-related quality of life (HRQoL) is an important aspect of the overall management of hepatitis B virus (HBV) infection, yet is not well characterized. Consequently we soug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4517434efd7883385c0063891b2477b2
https://pubmed.ncbi.nlm.nih.gov/18318043
https://pubmed.ncbi.nlm.nih.gov/18318043
Autor:
Belinda Mak, Aung Myat Oo, Chun-Tao Wai, Winnie Chua, Chee Leong Cheng, Aileen Wee, Edwin Chan, Seng Gee Lim, Yock Young Dan
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 26(6)
Background and aim: In contrast to chronic hepatitis C (CHC), few studies had been performed in assessing non-invasive models for predicting significant fibrosis or cirrhosis in chronic hepatitis B (CHB) patients. We aimed to evaluate non-invasive ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5598d8437b8cb580308d6be61b6779
https://pubmed.ncbi.nlm.nih.gov/16842322
https://pubmed.ncbi.nlm.nih.gov/16842322
Publikováno v:
The American Journal of Medicine. 120:e17-e18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8f4a753084927d94414077a77dd5c53
https://doi.org/10.1016/j.amjmed.2006.04.020
https://doi.org/10.1016/j.amjmed.2006.04.020
Publikováno v:
Gastroenterology. 138:S-831
Background: Entecavir is one of the treatment options for lamivudine-resistant hepatitis B patients though there is increased entecavir-resistance rate. The response of lamivudineresistant, adefovir poor-responders is unclear. Methods: We performed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f562e9a8d10ed3c8ea4e4fd0538771d1
https://doi.org/10.1016/s0016-5085(10)63829-2
https://doi.org/10.1016/s0016-5085(10)63829-2
Autor:
Seng Gee Lim, Winnie Chua, Mee Lian Wong, Chun-Tao Wai, Amelia Cheok, Seline Ng, Mei-Hua Tan, Belinda Mak
Publikováno v:
World Journal of Gastroenterology. 11:5002
AIM: To identify the misperceptions among CHB patients, as well as to determine the factors associated with better knowledge. METHODS: A telephone interview was conducted on 192 adult CHB patients, who earlier responded to an advertisement for free s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe0ab3c570fb5a46684d06c87636a2f8
https://doi.org/10.3748/wjg.v11.i32.5002
https://doi.org/10.3748/wjg.v11.i32.5002
Publikováno v:
Hepatology. 38:693-693
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74682c6800b93b6ddfde121681112839
https://doi.org/10.1016/s0270-9139(03)81154-0
https://doi.org/10.1016/s0270-9139(03)81154-0